Related Experiment Video
Updated: Nov 10, 2025

Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
Subacute vision loss after microvascular decompression for trigeminal neuralgia
Kevin Zhao1, Justin Gold1, Grant Arzumanov1
1Department of Neurological Surgery, New Jersey Medical School, Rutgers University, 90 Bergen Street, Suite 8100, Newark, NJ, 07103, USA.
Microvascular decompression for trigeminal neuralgia can rarely cause delayed vision loss. This occurs due to transverse sinus stenosis from bone wax, leading to increased intracranial pressure.
Area of Science:
- Neurosurgery
- Ophthalmology
- Vascular Surgery
Background:
- Microvascular decompression (MVD) is the primary surgical treatment for medically refractory trigeminal neuralgia (TN).
- While MVD is generally safe, potential complications require ongoing investigation.
- Delayed visual complications post-MVD are exceptionally rare.
Observation:
- A patient experienced delayed visual loss and papilledema following MVD for TN.
- The visual disturbances were attributed to transverse sinus stenosis.
- The stenosis resulted from bone wax compression during the retrosigmoid craniotomy.
Findings:
- Bone wax used during retrosigmoid craniotomy can inadvertently compress the transverse sinus.
- This compression can lead to venous sinus stenosis and subsequent intracranial hypertension.
- Delayed visual loss and papilledema are potential sequelae of such venous compromise.
Implications:
- Meticulous attention is crucial during MVD to prevent iatrogenic venous sinus stenosis.
- Neurosurgeons must ensure bone wax placement does not obstruct venous drainage.
- Awareness of this rare complication is vital for timely diagnosis and management of visual disturbances after MVD.
More Related Videos
04:06Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line
Published on: September 13, 2024
13:12Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Published on: October 15, 2017
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview